Literature DB >> 26674261

Current Perspective on the Pathogenesis of Small Intestinal Neuroendocrine Tumors: Progress in Biomarkers and Molecular Events.

Ying-Xuan Chen1, Jing-Yuan Fang1.   

Abstract

BACKGROUND: Neuroendocrine tumors of the gastrointestinal tract differ in their histopathologic and clinical presentation. Small intestinal neuroendocrine tumors (SI-NETs), representing only a small portion within gastrointestinal malignancies, are often associated with a delayed diagnosis due to their non-specific symptoms. The increased incidence of SI-NETs during the last decades demands earlier diagnosis and more effective treatment, which both rely on a better understanding on the underlying molecular mechanisms.
SUMMARY: The purpose of this review is to discuss the biomolecular changes responsible for the pathogenesis of SI-NETs, and potential biomarkers in the diagnostic and prognostic evaluation.

Entities:  

Keywords:  Biomolecular changes; Ileal carcinoid; Neuroendocrine tumors; Small intestinal; Tumor biomarkers

Year:  2013        PMID: 26674261      PMCID: PMC4645569          DOI: 10.1159/000354993

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  33 in total

Review 1.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

2.  DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.

Authors:  Md Mustafizur Rahman; Zhi Rong Qian; Elaine Lu Wang; Katsuhiko Yoshimoto; Masahiko Nakasono; Razia Sultana; Tomoyuki Yoshida; Toshitetsu Hayashi; Reiji Haba; Mitsuaki Ishida; Hidetoshi Okabe; Toshiaki Sano
Journal:  Hum Pathol       Date:  2010-04-08       Impact factor: 3.466

3.  Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.

Authors:  Sofia Vikman; Magnus Essand; Janet L Cunningham; Manuel de la Torre; Kjell Oberg; Thomas H Tötterman; Valeria Giandomenico
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

4.  Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior.

Authors:  Thomas M O'Dorisio; Siegfried R Krutzik; Eugene A Woltering; Erika Lindholm; Saju Joseph; Abby E Gandolfi; Yi-Zarn Wang; J Phillip Boudreaux; Aaron I Vinik; Vay Liang W Go; James R Howe; Thor Halfdanarson; M Sue O'Dorisio; Gregg Mamikunian
Journal:  Pancreas       Date:  2010-07       Impact factor: 3.327

5.  Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas.

Authors:  Justyna Leja; Ahmed Essaghir; Magnus Essand; Kenneth Wester; Kjell Oberg; Thomas H Tötterman; Ricardo Lloyd; George Vasmatzis; Jean-Baptiste Demoulin; Valeria Giandomenico
Journal:  Mod Pathol       Date:  2008-10-24       Impact factor: 7.842

6.  Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.

Authors:  Irvin M Modlin; Björn I Gustafsson; Ignat Drozdov; Boaz Nadler; Roswitha Pfragner; Mark Kidd
Journal:  Ann Surg Oncol       Date:  2008-12-03       Impact factor: 5.344

7.  Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.

Authors:  Mark Kidd; Irvin M Modlin; Roswitha Pfragner; Geeta N Eick; Manish C Champaneria; Anthony K Chan; Robert L Camp; Shrikant M Mane
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

8.  Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.

Authors:  Eva-Maria Duerr; Yusuke Mizukami; Aylwin Ng; Ramnik J Xavier; Hirotoshi Kikuchi; Vikram Deshpande; Andrew L Warshaw; Jonathan Glickman; Matthew H Kulke; Daniel C Chung
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

9.  Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.

Authors:  Amitabh Srivastava; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2009-04       Impact factor: 6.394

10.  Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors.

Authors:  He-Yu Zhang; Kandelaria M Rumilla; Long Jin; Nobuki Nakamura; Gail A Stilling; Katharina H Ruebel; Timothy J Hobday; Charles Erlichman; Lori A Erickson; Ricardo V Lloyd
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.633

View more
  1 in total

1.  A Call to Action: Intensify the Investigation of Relatively Rare Tumors of the Gastrointestinal Tract.

Authors:  Le Shen; Jing-Yua Fang
Journal:  Gastrointest Tumors       Date:  2015-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.